Lyra Therapeutics, Inc. (LYRA) has seen some recent action in the market and its shares closed at $11.00 yesterday. People are starting to take notice of LYRA as the shares traded as high as $11.41 and as low as $10.93 in the previous market session.
Lyra Therapeutics, Inc. (LYRA) average trading volume is 33.45K. However, in the previous market session Lyra Therapeutics, Inc. (LYRA) traded 73,465 shares. The 1st support level on LYRA is $10.69 and the 1st resistance level on LYRA is $16.45. LYRA 50day moving average is $11.79 and LYRA 200 day moving average is $13.07.
Lyra Therapeutics, Inc. (LYRA) most recent performance has been specified by the recent movement in LYRA shares. LYRA has performed -1.61% over the past 4 weeks, LYRA has performed -17.91% over the past quarter and LYRA has shown – over the past 365 days. Lyra Therapeutics, Inc. (LYRA) has a 52 week range of $10.44 to $22.00. Lyra Therapeutics, Inc. (LYRA) is trading 5.36% from its 52 week low and -50.00% from its 52 week high. Lyra Therapeutics, Inc. (LYRA) is indicating a 1.58% short float indicating the amount short in the float.
LYRA has 12.40M shares outstanding and 9.52M shares in the float. Lyra Therapeutics, Inc. (LYRA) presently has a market cap of $141.68M and income of -17.20M. The EPS next quarter for LYRA is -0.41 and projected EPS next year is 17.30%. The market cap of Lyra Therapeutics, Inc. (LYRA) at $141.68M represents how many People own shares of LYRA and is calculated off the last price ($11.00) of LYRA and the amount of shares outstanding (12.40M) with Lyra Therapeutics, Inc. (LYRA).
Lyra Therapeutics, Inc. (LYRA) has total cash (mrq) of 86.6M, total cash per share (mrq) of 6.7, total debt of LYRA is at 2.9M and total debt/equity (mrq) is 3.34. . Lyra Therapeutics, Inc. (LYRA) running cash flow (ttm) is -19.24M.
LYRA is trading -7.85% below (bearish) its SMA20, -9.56% below (bearish) its SMA50 and -15.94% below (bearish) its SMA200.